References
- Chisari F V, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis-B virus transgenic mice. Cell 1989; 5: 1145–56
- Sell S, Hunt J M, Dunsord H A, Chisari F V. Synergism between hepatitis-B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 1991; 51: 1278–85
- Stanbridge E J. Human tumour-suppressor genes. Annu Rev Genet 1990; 24: 615–57
- Harris A L. Telling changes of base. Nature 1991; 350: 377–8
- Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science 1991; 253: 49–53
- Bressac B, Galvin K M, Liang T J, Isselbacher K J, Wands J R, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 1973–7
- Hsu I C, Metcalf R A, Sun T, Welsh J A, Wang N J, Harris C C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427–8
- Bressac B, Kew M C, Wands J R, Ozturk M. Selective G to T mutations of p53 in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429–31
- Ozturk M, collaborators. p53 in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338: 1356–9
- Muench K F, Misra R P, Humayun M Z. Sequence specificity in aflatoxin Bl-DNA interactions. Proc Natl Acad Sci USA 1983; 80: 6–10
- DeJean A, Bougueleret L, Grzeschik K H, Tiollais P. Hepatitis-B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986; 322: 70–2
- Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis-B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990; 343: 555–7
- Robinson W S, Klote L, Aoki N. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol 1990; 31: 18–32
- Hsu T, Moroy T, Etiemble J, et al. Activation of C-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 1988; 55: 627–35
- Twu J S, Schloemer R H. Transcriptional trans-activating function of hepatitis-B virus. J Virol 1987; 61: 3448–53
- Spandau D F, Lee C H. Trans-activation of viral enhancers by the hepatitis-B virus X gene protein. J Virol 1988; 62: 427–34
- Kim C-M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis-B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317–20
- Lee T-H, Finegold M-J, Shen R F, DeMoyo J L, Woo S LC, Butel J S. Hepatitis-B virus trans-activator X protein is not tumorigenic in transgenic mice. J Virol 1990; 64: 5939–47
- Kekule A, Lauer U, Meyer M, Caselmann W, Hofschneider P A, Koshy K. The preS/S region of integrated hepatitis-B virus encodes a transcriptional trans-activator. Nature 1990; 343: 457–60
- Wang H P, Rogler C E. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J Virol 1991; 65: 2381–92
- Jeng J-E, Tsai J-F. Hepatitis-C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 1991; 34: 74–7
- Kew M C, Houghton M, Choo Q-L, Kuo G. Hepatitis-C antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873–4
- Nishioka K, Watanabe J, Furuta S., et al. A high prevalence of antibody to the hepatitis-C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429–33
- Bruix J, Barrera J M, Calvet X, et al. Prevalence of antibodies to hepatitis-C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 334: 1004–6
- Columbo M, Kuo G, Choo Q-L, et al. Prevalence of antibodies to hepatitis-C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 334: 1006–8
- Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 1974–6
- DiBisceglie A M, Order S E, Klein J L, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United Stgues. Am J Gastroenterol 1991; 86: 335–8
- Yu M C, Tong M J, Coursaget P, Ross R K, Govindarajan S, Henderson B E. Prevalence of hepatitis B and C viral markers in black and white patients in the United States. J Natl Cancer Inst 1990; 82: 1038–41
- Kew M C. Detection and treatment of small hepatocellular carcinomas. Viral hepatitis and liver disease, E B Hollinger, S M Lemon, H S Margolis. Williams & Wilkins, Baltimore 1991; 535–40
- Lipiodol computed tomography in the diagnosis of small hepatocellular carcinomas. Lancet 1991; 337: 333–4